Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Primordia Lifesciences is an Indian private biotechnology startup focused on molecular diagnostics, sample processing solutions, and related genomics products and services. The company markets DNA and RNA extraction kits, molecular biology reagents, apoptosis detection reagents, RNA stabilization products, and training/services in molecular biology and cell culture. Its positioning appears to be centered on cost-effective, time-efficient diagnostic assays and point-of-care testing for infectious diseases, particularly for resource-constrained settings. Primordia Lifesciences also provides customized genomics services and educational training programs, suggesting a mix of product sales and service revenue rather than a traditional therapeutic drug-development model. The company appears to be active, privately held, and operating primarily from Kerala, India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Primordia Lifesciences.